BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19022159)

  • 1. Steatosis and diastolic dysfunction: the skinny on myocardial fat.
    Lindsey JB; Marso SP
    J Am Coll Cardiol; 2008 Nov; 52(22):1800-2. PubMed ID: 19022159
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
    Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
    J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus.
    Ng AC; Delgado V; Bertini M; van der Meer RW; Rijzewijk LJ; Hooi Ewe S; Siebelink HM; Smit JW; Diamant M; Romijn JA; de Roos A; Leung DY; Lamb HJ; Bax JJ
    Circulation; 2010 Dec; 122(24):2538-44. PubMed ID: 21126971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fatty hearts of patients with diabetes.
    Lingvay I; Raskin P; Szczepaniak LS
    Nat Rev Cardiol; 2009 Apr; 6(4):268-9. PubMed ID: 19352328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a
    Gao Y; Ren Y; Guo YK; Liu X; Xie LJ; Jiang L; Shen MT; Deng MY; Yang ZG
    Cardiovasc Diabetol; 2020 May; 19(1):70. PubMed ID: 32471503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function.
    Hammer S; Snel M; Lamb HJ; Jazet IM; van der Meer RW; Pijl H; Meinders EA; Romijn JA; de Roos A; Smit JW
    J Am Coll Cardiol; 2008 Sep; 52(12):1006-12. PubMed ID: 18786482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac steatosis and left ventricular function in men with metabolic syndrome.
    Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
    J Cardiovasc Magn Reson; 2013 Nov; 15(1):103. PubMed ID: 24228979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy in myocardial disease.
    Beadle R; Frenneaux M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):269-77. PubMed ID: 20136613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance.
    Ritchie RH
    Heart Lung Circ; 2009 Feb; 18(1):11-8. PubMed ID: 19119069
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial lipid accumulation in the diabetic heart.
    Ruberg FL
    Circulation; 2007 Sep; 116(10):1110-2. PubMed ID: 17768302
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic derangements in the insulin-resistant heart.
    Govindarajan G; Hayden MR; Cooper SA; Figueroa SD; Ma L; Hoffman TJ; Stump CS; Sowers JR
    J Cardiometab Syndr; 2006; 1(2):102-6. PubMed ID: 17679814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences.
    Toribio M; Neilan TG; Awadalla M; Stone LA; Rokicki A; Rivard C; Mulligan CP; Cagliero D; Fourman LT; Stanley TL; Ho JE; Triant VA; Burdo TH; Nelson MD; Szczepaniak LS; Zanni MV
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6090-6100. PubMed ID: 31393564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very-low-calorie diet increases myocardial triglyceride content and decreases diastolic left ventricular function in type 2 diabetes with cardiac complications.
    Jonker JT; Djaberi R; van Schinkel LD; Hammer S; Bus MT; Kerpershoek G; Kharagjitsingh AV; Romijn JA; Bax JJ; Jukema JW; de Roos A; Smit JW; Lamb HJ
    Diabetes Care; 2014; 37(1):e1-2. PubMed ID: 24356600
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy.
    Zhang Y; Ren J
    Hypertension; 2011 Feb; 57(2):148-50. PubMed ID: 21220703
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study.
    Nakanishi T; Kato S
    Pathol Res Pract; 2014 Dec; 210(12):1018-25. PubMed ID: 24836730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Renaissance of vascular endothelial growth factor, part B.
    Schaper W
    Circ Res; 2008 Oct; 103(9):903-4. PubMed ID: 18948625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relations between the seasonal changes in the myocardial contraction and various indices of lipid metabolism in damaged myocardium].
    Frolov VA; Efimov LV
    Biull Eksp Biol Med; 1982 Oct; 94(10):20-2. PubMed ID: 7171793
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiology for physicians. Metabolic acidosis and myocardial contractility in hyperkalemic myocardopathy.
    Ojiambo HP
    East Afr Med J; 1971 Apr; 48(4):196-9. PubMed ID: 5129680
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of myocardial disorders by magnetic resonance spectroscopy.
    Hudsmith LE; Neubauer S
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S49-56. PubMed ID: 18641607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pathogenetic aspects of diabetic involvement of the heart].
    Kubyshkin VF; Ushakov AV; Legkonogov AV
    Lik Sprava; 2000; (1):54-6. PubMed ID: 10878978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.